Skip to main content
. 2023 Apr 17;13(4):565. doi: 10.3390/metabo13040565

Table 1.

Description of the whole sample according to population setting, i.e., northern (clinical setting) versus southern (population-based setting) Italy.

Clinical-Based Subset (Pavia) Population-Based Subset (Apulia)
Mean ± SD Median (IQR) Mean ± SD Median (IQR) Wilcoxon’s ES
Prop. (%) 1312 (73.30) 479 (26.70)
Age (years) 79.79 ± 7.18 80 (10) 74.81 ± 5.67 74.09 (7.58) 0.32 (0.28 to 0.36)
Sex
Female 949 (72.30) 255 (53.20) 19.10 (14.01 to 24.18)
Male 363 (27.70) 224 (46.80)
Sarcopenia 165 (12.60) 35 (7.30) −5.27 (−8.21 to −2.33)
Albumin (g/dL) 3.67 ± 0.51 3.74 (0.67) 4.08 ± 0.42 4.05 (0.4) 0.37 (0.34 to 0.41)
AST (U/L) 18.65 ± 17.7 14 (10) 20.39 ± 9.33 19 (8) 0.26 (0.22 to 0.30)
BMI (kg/m2) 25.57 ± 5.88 24.7 (6.7) 29.75 ± 4.94 29.32 (6.08) 0.26 (0.22 to 0.30)
CRP (mg/dL) 1.25 ± 2.63 0.35 (0.84) 0.43 ± 0.62 0.43 (0.33) 0.02 (−0.01 to 0.05)
FBG (mg/dL) 108.19 ± 41.06 96 (33) 102.68 ± 25.31 96 (21) 0.01 (−0.03 to 0.03)
FFM arms (kg) 4.12 ± 1.38 3.86 (1.70) 4.71 ± 1.354 4.51 (2.15) 0.20 (0.16 to 0.24)
FFM legs (kg) 13.419 ± 3.21 12.98 (4.33) 13.24 ± 3.02 13.14 (4.71) 0.02 (−0.03 to 0.04)
Folate (ng/mL) 9.13 ± 9.19 5.9 (7.82) 8.98 ± 5.95 7.6 (5.3) 0.11 (0.08 to 0.16)
FT3 (pmol/L) 2.32 ± 0.53 2.3 (0.64) 3.32 ± 0.39 3.32 (0.46) 0.67 (0.65 to 0.70)
FT4 (pmol/L) 5.76 ± 5.74 1.46 (9.78) 0.97 ± 0.66 0.9 (0.19) 0.54 (0.51 to 0.58)
GGT (U/L) 32.98 ± 42.09 20 (18) 19.44 ± 16.61 15 (9) 0.21 (0.17 to 0.26)
HGS (kg) 18.68 ± 7.74 18 (9.33) 23.13 ± 8.28 22 (11.67) 0.24 (0.20 to 0.29)
HDL Cholesterol (mg/dL) 47.96 ± 17.65 47 (21) 52.41 ± 14.02 52 (17) 0.12 (0.08 to 0.17)
Height (cm) 156.79 ± 9.62 155 (13) 157.45 ± 9.03 157 (13) 0.04 (−0.01 to 0.09)
Haemoglobin (g/dL) 12.35 ± 1.72 12.4 (2.2) 13.68 ± 1.44 13.7 (1.8) 0.35 (0.31 to 0.39)
LDL Cholesterol (mg/dL) 111.76 ± 37.32 107.9 (48.85) 104.9 ± 32.66 104 (49) 0.07 (0.20 to 0.12)
Neck BMD 0.74 ± 0.18 0.73 (0.2) 0.77 ± 0.58 0.7 (0.17) 0.04 (0.01 to 0.09)
Platelets (103 cells/mm3) 247.02 ± 103.99 238.6 (103.72) 230.55 ± 71.2 226 (75.5) 0.07 (0.03 to 0.12)
RBC (106 cells/mm3) 4.18 ± 0.65 4.17 (0.69) 4.66 ± 0.55 4.66 (0.62) 0.38 (0.34 to 0.42)
SMI (kg/m2) 7.08 ± 1.37 7 (1.72) 7.17 ± 1.18 7.1 (1.75) 0.03 (−0.01 to 0.08)
SPPB score 6.26 ± 3.04 6 (5) 8.27 ± 2.86 9 (5) 0.28 (0.25 to 0.33)
Total Cholesterol (mg/dL) 185.68 ± 41.34 184.5 (58) 180.14 ± 37.31 179 (50.5) 0.05 (0.01 to 0.10)
Triglycerides (mg/dL) 132.2 ± 80.08 111 (75.25) 113.56 ± 75.43 93 (63.5) 0.13 (0.09 to 0.18)
TSH (µU/mL) 2.13 ± 2.28 1.5 (1.61) 1.87 ± 1.76 1.55 (1.29) 0.01 (−0.03 to 0.03)
Vitamin D (nmol/L) 13.29 ± 10.77 10.2 (10.2) 27.98 ± 12.69 26.4 (12.7) 0.54 (0.51 to 0.58)
WBC (103 cells/mm3) 7.01 ± 3.14 6.54 (2.41) 6.36 ± 1.81 6.09 (2.13) 0.10 (0.06 to 0.15)
Whole Body Fat (kg) 22.60 ± 10.46 21.30 (13.26) 30.04 ± 8.943 28.68 (11.84) 0.34 (0.30 to 0.38)
Whole Body Lean Mass (kg) 38.84 ± 7.928 37.29 (10.52) 42.77 ± 8.503 41.61 (13.56) 0.20 (0.16 to 0.25)
Whole Body Mass (kg) 63.43 ± 15.59 61.70 (20.01) 72.82 ± 13.93 72.34 (18.93) 0.28 (0.25 to 0.33)
Weight (kg) 62.85 ± 15.53 60.55 (19.2) 73.86 ± 14.31 72.6 (18.7) 0.33 (0.30 to 0.37)

n = 1791. All data are shown as mean ± SD, median (min to max) for continuous variables and as n (%) for proportions. Statistically significant data are indicated in bold type. Abbreviations: AST: aspartate aminotransferase; BMI: body mass index; CRP: C-reactive protein; FBG: fasting blood glucose; FFM: fat-free mass; GGT: gamma-glutamyl transferase; HGS: handgrip strength; BMD: bone mineral density; RBC: red blood cells; SMI: skeletal muscle index; SPPB: Short Physical Performance Battery; TSH: thyroid-stimulating hormone.